Parallax Volatility Advisers, L.P. Kiniksa Pharmaceuticals, Ltd. Call Options Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$13.62 - $20.2 $476,700 - $707,000	-35,000 Reduced 53.76%	30,100 $522,000
Q2 2023 Aug 14, 2023	BUY	$10.44 - $16.48 $313,200 - $494,400	30,000 Added 85.47%	65,100 $916,000
Q1 2023 May 15, 2023	BUY	$10.7 - $15.79 $375,570 - $554,229	35,100 New	35,100 $377,000
Q3 2022 Nov 14, 2022	SELL	$9.76 - $13.41 $19,520 - $26,820	-2,000 Reduced 11.76%	15,000 $193,000
Q2 2022 Aug 15, 2022	BUY	$7.6 - $11.41 $129,200 - $193,970	17,000 New	17,000 $164,000
Q3 2021 Nov 15, 2021	SELL	$11.39 - $16.23 $85,425 - $121,725	-7,500 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$16.68 - $23.97 $125,100 - $179,775	7,500 New	7,500 $139,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $693M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.